Loxo, Bayer to co-develop cancer drugs in up to $1.55 billion deal

(Reuters) - Loxo Oncology Inc will collaborate with Germany's Bayer AG to develop and commercialize two of its cancer therapies, the companies said on Tuesday, in deal that could bring the U.S. drug developer up to $1.55 billion.

from Reuters: Health News http://reut.rs/2zYhN58